All lobbying filings

MILLER STRATEGIES, LLC

MILLER STRATEGIES, LLC filed a Q3 report for GILEAD SCIENCES, INC. on October 20, 2026, reporting $150,000 in lobbying income.

Lobbying for GILEAD SCIENCES, INC. · Biopharmaceutical company

All filings by MILLER STRATEGIES, LLC · Everything GILEAD SCIENCES, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$150,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

JAMES MIN

Previously held: \

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 3

Health Issues

Issues related to pharmaceuticals and drug development.

Budget/Appropriations

Issues related to pharmaceuticals and drug development.

Medicare/Medicaid

Issues related to pharmaceuticals and drug development.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.